CAR T: A Review of Clinical Data for Second Line Treatments

Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.

Related Keywords

, Transforming Largeb Cell Lymphoma , Novel Agents , Clinical Data , Second Line Treatments , Largeb Cell , Dlbcl , Lymphoma , Largeb Cell Lymphoma , Car T , Cart Cell , Cart Cell Therapy , Cart Cell Therapy Lymphoma , Cart Cell Therapy Largeb Lymphoma , Patients With Lbcl , Patients With Largeb Cell Lymphoma , Mechanisms Of Action , Clinical Applications ,